The Elmore Oil Company, a Bendigo based company who manufactures a topical pain relief
lotion for arthritis and muscular pain recently undertook a double blind, placebo controlled
trial for their flagship product, Elmore Oil.
The trial was headed by Dr. Ruth S. Sy, head Rheumatologist at the Veterans Memorial
Hospital in Quezon City and coordinated by respected researcher, Dr. Leticia LuceroPalma.
In what could be a major breakthrough in medical science, all the patients in the trial have
recorded reduced uric acid levels after being on Elmore Oil for as little as 4 weeks.
The trial was set up to study the effects of Elmore Oil against a placebo, on patients aged
between 45 and 90 years of age, who have been clinically diagnosed with osteoarthritis. The
patients all recorded their pain levels in a detailed diary but they have also been blood tested
prior to the trial and weekly thereafter.
Dr. Palma noticed a marked drop in uric acids levels in all patients, up to 50% in some cases,
which has led to an excited optimism that the company may have stumbled on a potential cure
for gout. While it is too early to make assumptions the company is prepared to fund more
research into the potential cure.
A story on the effects of the product for arthritis as well as the potential for gout prevention
will be aired on Australias leading news program, A Current Affair, in the week before Easter.
Elmore Oil is a simple blend of Olive Oil, Eucalyptus Oil, Tea Tree Oil and specially
prepared extracts of Vanilla. The companies Managing Director, Mark Linford, says the
secret behind Elmore Oil is its unique blending process.
“Elmore Oil is manufactured using a process known as Triple Maturation. It’s unique to
Elmore Oil and it bonds the actives in the essentials oils to the circulatory components found
in Vanilla so we have a product which enters the body quickly and gets to the source of the
pain and inflammation quickly.”
This advantage has been the driving factor behind the products spiralling popularity with the
elderly generation for arthritis pain relief, but it has also struck favour with the younger and
mid age groups as a recovery product for exercise and sport. Now with the potential to be
used as a preventative for gout the product could be set for multi national fame.
“We are hopeful that the next phase of the trial can isolate the components that are lowering
the uric acid levels and allow us to pin point the science behind this amazing revelation.”
Gout currently affects 16 million people worldwide and is in itself a form of arthritis. It most
frequently effects men ages between 40 and 60 years of age and in 75% of the cases the first
attack occurs in the big toe. Gout occurs as a result of excess uric acid in the blood and
tissues. If uric acid crystals enter the joint, they may trigger the development of inflammation.
For more information on Elmore Oil call 1800 330 681 or visit www.elmoreoil.com.au
Elmore Oil Company
5 Rohs Road
Bendigo VIC 3550
Ph: 03 5443 9411
Fax: 03 5443 9422